Strong Growth Ahead: Diabetes Care Devices Market Size To Grow At Arecord 12.3% Cagr By 2029

The Diabetes Care Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Diabetes Care Devices Market Size Expected to Be by 2034?
There has been a substantial expansion in the market size of diabetes care devices in past years. The growth is expected to surge from $67.88 billion in 2024 to $76.22 billion in 2025, with a compound annual growth rate (CAGR) of 12.3%. The historic period's progression can be linked to factors such as a rise in diabetes cases, economic development, reforms in public healthcare insurance, an upsurge in the elderly population, along with increased spending on healthcare.

The market size for diabetes care devices is anticipated to witness substantial growth in the coming years, reaching a value of $121.11 billion by 2029 with a compound annual growth rate (CAGR) of 12.3%. Several factors driving the growth over the forecast period include enhanced research and development investments, growing disease prevalence, governmental support, and technological advancement. The forecast period is expected to see key developments such as needle-free glucose testing, glucose-responsive insulins (GRIS), artificial pancreas, a shift away from traditional insulin syringes, and the advent of wearable and mobile glucose monitoring systems, as well as smart glucose meters.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3609

What Are the Emerging Segments Within the Diabetes Care Devices Market?
The diabetes care devices market covered in this report is segmented -

1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters
2) By Type of Expenditure: Public, Private
3) By Product: Instruments Or Equipment, Disposables
4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:
1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors
2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens
3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes
4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps
5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)
6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters
7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

What Long-Term Drivers Are Shaping Diabetes Care Devices Market Trends?
The escalation of healthcare costs is predicted to fuel the expansion of the diabetes care device market in the future. This relate to the cumulative sum allocated to healthcare services, commodities, and activities within a certain timeline, usually at individual, communal, national, or global level. The surge in healthcare expenditures, along with enhanced accessibility to healthcare services and an increase in diabetes diagnoses, trigger more significant investments into research and development. This further results in the progression of diabetes care devices like advanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For instance, data from the Europe-based governmental agency, Eurostat, shows that the EU's spending on sickness and healthcare reached 8.1% of GDP in 2022. Out of the 24 EU nations with available data, France topped the list with an expenditure of 10.0%, followed by Germany at 9.7%, while Bulgaria had the least at 4.2%. Countries with low spending also included Ireland (4.6%), Hungary and Lithuania (4.7%), and Estonia (4.8%). Hence, the rise in healthcare spending will be a significant driver in the progress of the diabetes care device market in the future.

Who Are the Top Competitors in Key Diabetes Care Devices Market Segments?
Major companies operating in the diabetes care devices market include Becton Dickinson and Company, Roche Holding AG, Nipro Corporation, HTL-STREFA Inc., ARKRAY, Terumo Corporation, Owen Mumford, Ypsomed AG, Vogt Medical, Sanofi India, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Medtronic, Emperra GmbH E-Health, Novo Nordisk A/S, Insujet, Eli Lilly, Fresenius Medical Care, Siemens, Stryker, Teleflex Medical, LifeScan, Ascensia Diabetes Care, Tandem Diabetes Care, Dexcom Inc., SocialDiabetes, Dottli, Themis Bioscience, Ok biotech, Acon Laboratories, Bayer AG, AgaMatrix.

What Diabetes Care Devices Market Trends Are Gaining Traction Across Different Segments?
Top players in the diabetes care devices market, such as Medtronic, are concentrating on the development of innovative products like the Medtronic Extended Infusion, with a goal to increase their market profitability. This infusion set, which is a tube transporting insulin from its pump into the body, is designed for usage over a span of a week (7 days). For example, in November 2022, Medtronic, an American medical device corporation, introduced the Medtronic Extended infusion set to the market. This product makes use of highly advanced materials to restrict the loss of insulin preservatives and to improve the flow, thereby effectively doubling the lifespan of the set. Its creative design, which consists of a new and improved tubing connector and a long-lasting adhesive patch, ensures the stability of insulin and comfort for the patient for up to a week.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Which Regions Are Becoming Hubs for Diabetes Care Devices Market Innovation?
North America was the largest region in the global diabetes care devices market in 2024. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diabetes Care Devices Market?
2. What is the CAGR expected in the Diabetes Care Devices Market?
3. What Are the Key Innovations Transforming the Diabetes Care Devices Industry?
4. Which Region Is Leading the Diabetes Care Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.